Metabolic engineering of Escherichia coli to efficiently produce 3-deacyl-2-acyloxyacyl-4′-monophosphoryl-lipid A

Abstract

3-O-Deacyl-2-O-palmitoyl-4′-monophosphoryl lipid A (MPL) has recently been used in vaccine adjuvant. In this study, an E. coli mutant WZM012 which can effectively produce MPL has been constructed from E. coli MG1655 by genome editing. First, the genes mlaE, pldA, and hns related to the phospholipid transport system in membrane were deleted in MG1655 to accumulate more phospholipid substrate for PagP. In addition, the gene FnlpxE from Francisella novicida which can remove the phosphate group at 1-position of lipid A and the gene SepagL from Salmonella which can remove the acyl chain at 3-position of lipid A were inserted into the chromosome to replace the gene clusters ybgC-cpoB and letAB, respectively, resulting in the strain WZM012. After 24 h fed-batch fermentation of WZM012, lipid A species were isolated and analyzed using thin-layer chromatography and liquid chromatography–mass spectrometry, and 32.76 mg/L MPL was obtained. This engineered E. coli strain could be developed for industrial MPL production.

Keywords

Escherichia coli / Lipid A / Monophosphoryl lipid A / MPL / Lipopolysaccharide

References

1.	Wang X, Quinn PJ. Lipopolysaccharide: biosynthetic pathway and structure modification. Prog Lipid Res, 2010, 49(2): 97-107,
2.	Wang X, Quinn PJ, Yan A. Kdo2-lipid a: structural diversity and impact on immunopharmacology. Biol Rev Camb Philos Soc, 2015, 90(2): 408-427,
3.	Zhao Y, Arce-Gorvel V, Conde-Alvarez R, Moriyon I, Gorvel JP. Vaccine development targeting lipopolysaccharide structure modification. Microbes Infect, 2018, 20(9–10): 455-460,
4.	Lu YC, Yeh WC, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine, 2008, 42(2): 145-151,
5.	Wang X, Quinn PJ. Endotoxins: lipopolysaccharides of gram-negative bacteria. Subcell Biochem, 2010, 53: 3-25,
6.	Moingeon P, Haensler J, Lindberg A. Towards the rational design of Th1 adjuvants. Vaccine, 2001, 19: 4363-4372,
7.	Casella CR, Mitchell TC. Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant. Cell Mol Life Sci, 2008, 65(20): 3231-3240, pmcid: 2647720
8.	Alving CR, Peachman KK, Rao M, Reed SG. Adjuvants for human vaccines. Curr Opin Immunol, 2012, 24(3): 310-315, pmcid: 3383374
9.	Needham BD, Carroll SM, Giles DK, Georgiou G, Whiteley M, Trent MS. Modulating the innate immune response by combinatorial engineering of endotoxin. PNAS, 2013, 110(4): 1464-1469, pmcid: 3557076
10.	Han Y, Li Y, Chen J, Tan Y, Guan F, Wang X. Construction of monophosphoryl lipid A producing Escherichia coli mutants and comparison of immuno-stimulatory activities of their lipopolysaccharides. Mar Drugs, 2013, 11(2): 363-376, pmcid: 3640385
11.	Ji Y, An J, Hwang D, Ha DH, Lim SM, Lee C, Zhao J, Song HK, Yang EG, Zhou P, Chung HS. Metabolic engineering of Escherichia coli to produce a monophosphoryl lipid A adjuvant. Metab Eng, 2020, 57: 193-202,
12.	Wang Z, Zhao A, Wang C, Huang D, Yu J, Yu L, Wu Y, Wang X. Metabolic engineering of Escherichia coli to efficiently produce monophosphoryl lipid A. Biotechnol Appl Biochem, 2023, 2023: 1
13.	Wang X, Karbarz MJ, McGrath SC, Cotter RJ, Raetz CR. MsbA transporter-dependent lipid A 1-dephosphorylation on the periplasmic surface of the inner membrane: topography of Francisella novicida LpxE expressed in Escherichia coli. J Biol Chem, 2004, 279(47): 49470-49478,
14.	Trent MS, Pabich W, Raetz CR, Miller SI. A PhoP/PhoQ-induced Lipase (PagL) that catalyzes 3-O-deacylation of lipid A precursors in membranes of Salmonella typhimurium. J Biol Chem, 2001, 276(12): 9083-9092,
15.	Smith AE, Kim SH, Liu F, Jia W, Vinogradov E, Gyles CL, Bishop RE. PagP activation in the outer membrane triggers R3 core oligosaccharide truncation in the cytoplasm of Escherichia coli O157:H7. J Biol Chem, 2008, 283(7): 4332-4343,
16.	Malinverni JC, Silhavy TJ. An ABC transport system that maintains lipid asymmetry in the Gram-negative outer membrane. PNAS, 2009, 106: 8009-8014, pmcid: 2683108
17.	Szczesny M, Beloin C, Ghigo JM. Increased osmolarity in biofilm triggers rcsB-dependent lipid A palmitoylation in Escherichia coli. MBio, 2018, 9(4): 1,
18.	Lundstedt E, Kahne D, Ruiz N. Assembly, and maintenance of lipids at the bacterial outer membrane. Chem Rev, 2020, 121(9): 5098-5123, pmcid: 7981291
19.	Chong ZS, Woo WF, Chng SS. Osmoporin OmpC forms a complex with MlaA to maintain outer membrane lipid asymmetry in Escherichia coli. Mol Microbiol, 2015, 98(6): 1133-1146,
20.	Wang Z, Zhao A, Qiao J, Yu J, He F, Bi Y, Yu L, Wang X. Engineering Escherichia coli MG1655 to efficiently produce 3-deacyl-4′-monophosphoryl lipid A. J Agr Food Chem, 2023, 71(36): 13376-13390,
21.	Jiang Y, Chen B, Duan C, Sun B, Yang J, Yang S. Multigene editing in the Escherichia coli genome via the CRISPR-Cas9 system. Appl Environ Microbiol, 2015, 81(7): 2506-2514, pmcid: 4357945
22.	Wang X, Zhang C, Shi F, Hu X. Purification and characterization of lipopolysaccharides. Subcell Biochem, 2010, 53: 27-51,
23.	Zhao T, Cai Y, Jiang Y, He X, Wei Y, Yu Y, Tian X. Vaccine adjuvants: mechanisms and platforms. STTT, 2023, 8(1): 1
24.	Kool M, Fierens K, Lambrecht BN. Alum adjuvant: some of the tricks of the oldest adjuvant. J Med Microbiol, 2012, 61: 927-934,
25.	Jin H, Ji Y, An J, et al.. Engineering Escherichia coli for constitutive production of monophosphoryl lipid A vaccine adjuvant. Biotechnol Bioeng, 2024, 2024: 1
26.	Jacobson AN, Choudhury BP, Fischbach MA, Relman DA, Tang Y, Dorrestein P. The biosynthesis of lipooligosaccharide from Bacteroides thetaiotaomicron. bMio, 2018, 9(2): 1
27.	Barth M, Marschall C, Muffler A. Role for the histone-like protein H-NS in growth phase dependent and osmotic regulation of σS and many σS-dependent genes in Escherichia coli. J Bacteriol, 1995, 177(12): 3455-3464, pmcid: 177049
28.	Diaz-Ricci JC, Regan L, Bailey JE. Effect of the alteration of the acetic acid synthesis pathway on the fermentation pattern of Escherichia coli. Biotechnol Bioeng, 1991, 38: 1318-1324,

Funding

National Natural Science Foundation of China(NSFC32270102)